Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib.

Ann Rheum Dis

René Descartes University, Hôpital Cochin, Paris, France.

Published: August 2019

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691861	PMC
http://dx.doi.org/10.1136/annrheumdis-2018-214261	DOI Listing

Publication Analysis

efficacy safety

safety data

data based

based historical

historical pre-existing

pre-existing conditions

conditions baseline

baseline patients

patients active

active rheumatoid

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!